These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pyruvic and lactic acid metabolism in muscular dystrophy, neuropathies and other neuromuscular disorders. Goto I; Peters HA; Reese HH Am J Med Sci; 1967 Apr; 253(4):431-48. PubMed ID: 4290040 [No Abstract] [Full Text] [Related]
3. [Effect of ACTH upon the serum CPK activity in various neuromuscular diseases]. Araki S; Narazaki T; Kuroiwa Y Igaku To Seibutsugaku; 1967 Jan; 74(1):1-5. PubMed ID: 4292148 [No Abstract] [Full Text] [Related]
4. [The behavior of serum creatine phosphokinase in myopathies]. Iori E Boll Soc Ital Biol Sper; 1965 Dec; 41(23):1455-6. PubMed ID: 5878343 [No Abstract] [Full Text] [Related]
5. Free fatty acid concentrations in normal and diseased human muscle and in blood sera from patients with neuromuscular disease. Susheela AK Clin Chim Acta; 1968 Oct; 22(2):219-22. PubMed ID: 5687088 [No Abstract] [Full Text] [Related]
6. [Dilution effect of serum creatine phosphokinase and myoglobin in progressive muscular dystrophy]. Ohno T; Morikawa I; Suzuki T; Iwasa M; Mouri A No To Hattatsu; 1986 Sep; 18(5):418-20. PubMed ID: 3756026 [No Abstract] [Full Text] [Related]
7. Creatine phosphokinase of the blood serum in muscular disorders. Sercl M; Kovarík J; Tichý K; Kyral V; Lichý J Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1973; 16(3):129-45. PubMed ID: 4531711 [No Abstract] [Full Text] [Related]
8. [Serum creatine phosphokinase in various muscular diseases seen in the field of orthopedic surgery]. Iwamoto A Igaku Kenkyu; 1969 May; 39(2):108-21. PubMed ID: 5389323 [No Abstract] [Full Text] [Related]
10. Serum carnitine. An index of muscle destruction in man. DiMauro S; Scott C; Penn AS; Rowland LP Arch Neurol; 1973 Mar; 28(3):186-90. PubMed ID: 4685256 [No Abstract] [Full Text] [Related]
11. [Significances of the elevated activity of serum creatine phosphokinase and transaminase in progressive muscular dystrophy]. Kondo F; Ikeda M; Abe E; Mue S Iryo; 1966 Jul; 20(7):683-93. PubMed ID: 5981769 [No Abstract] [Full Text] [Related]
12. Response of serum creatine phosphokinase to steroid hormone. Takahashi K; Oimomi M; Shinko T; Shutta K; Matsuo B Arch Neurol; 1975 Feb; 32(2):89-91. PubMed ID: 1122183 [TBL] [Abstract][Full Text] [Related]
13. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers. Seay AR; Ziter FA; Wu LH; Wu JT Neurology; 1978 Oct; 28(10):1047-50. PubMed ID: 570660 [TBL] [Abstract][Full Text] [Related]
14. Serum creatine phosphokinase changes following needle electromyographic tudies. Cherington M; Lewin E; McCrimmon A Neurology; 1968 Mar; 18(3):271-2. PubMed ID: 5689668 [No Abstract] [Full Text] [Related]
15. The significance of the estimation of serum myoglobin in neuromuscular diseases. Hische EA; van der Helm HJ J Neurol Sci; 1979 Oct; 43(2):243-51. PubMed ID: 512682 [TBL] [Abstract][Full Text] [Related]
16. [Relationship between serum protein-bound iodine and serum creatine phosphokinase (CPK) activity in hypothyroidism in children]. Saito M Nihon Shonika Gakkai Zasshi; 1967 Feb; 71(2):149-55. PubMed ID: 4168827 [No Abstract] [Full Text] [Related]
17. Creatine phosphokinase activity in human polymorphonuclear leukocytes. Traniello S; D'Aloya MG; Grazi E Experientia; 1975 Mar; 31(3):278-80. PubMed ID: 234851 [No Abstract] [Full Text] [Related]
18. Duchenne muscular dystrophy: does serum myoglobin correlate with serum creatine kinase? Kiessling WR; Beckmann R Muscle Nerve; 1981; 4(3):257. PubMed ID: 7242564 [No Abstract] [Full Text] [Related]
19. Creatine phosphokinase isozymes in muscles. Human fetus and patients. Goto I; Nagamine M; Katsuki S Arch Neurol; 1969 Apr; 20(4):422-9. PubMed ID: 5816040 [No Abstract] [Full Text] [Related]